These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey. Demir T; Buyukguclu T Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831 [TBL] [Abstract][Full Text] [Related]
5. Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014. Bell JM; Turnidge JD; Coombs GW; Daley DA; Gottlieb T; Robson J; George N Commun Dis Intell Q Rep; 2016 Jun; 40(2):E229-35. PubMed ID: 27522134 [TBL] [Abstract][Full Text] [Related]
6. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2018. Bell JM; Gottlieb T; Daley DA; Coombs GW Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081651 [TBL] [Abstract][Full Text] [Related]
7. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019. Bell JM; Lubian AF; Partridge S; Gottlieb T; Iredell J; Daley DA; Coombs GA Commun Dis Intell (2018); 2020 Oct; 44():. PubMed ID: 33081652 [TBL] [Abstract][Full Text] [Related]
8. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2017. Bell JM; Gottlieb T; Daley DA; Coombs GW Commun Dis Intell (2018); 2019 Aug; 43():. PubMed ID: 31426735 [TBL] [Abstract][Full Text] [Related]
9. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Streit JM; Jones RN; Sader HS; Fritsche TR Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Lu PL; Liu YC; Toh HS; Lee YL; Liu YM; Ho CM; Huang CC; Liu CE; Ko WC; Wang JH; Tang HJ; Yu KW; Chen YS; Chuang YC; Xu Y; Ni Y; Chen YH; Hsueh PR Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S37-43. PubMed ID: 22749057 [TBL] [Abstract][Full Text] [Related]
12. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
13. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP). Bell JM; Lubian AF; Partridge SR; Gottlieb T; Robson J; Iredell JR; Daley DA; Coombs GW Commun Dis Intell (2018); 2022 Nov; 46():. PubMed ID: 36384435 [TBL] [Abstract][Full Text] [Related]